WIS received a copy of the transition agreement between Mr. Weeks and KershawHealth. The agreement stated Mr. Weeks would receive all compensation and benefits from now until he retires in January, and incentive pay for the year would be determined after Sept. 30.
Because Mr. Weeks decided to retire “prior to the conclusion of the contract term,” both parties agreed to pay him the $524,000 lump sum by his last day, according to the report.
In addition to the buyout, Mr. Weeks agreed to be available to consult with KershawHealth during its CEO transition.
More Articles on Hospital CEO Compensation:
Vanguard Adopts 6-Month Cash Bonus Program for Top Executives
Boston Teaching Hospital CEOs Continue to See 7-Figure Paydays
California Governor Signs Hospital CEO Pension Reform Bill
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
